Taiwan vaccine maker applies to conduct Phase 3 clinical trials in Paraguay
07/06/2021 09:47 PM
Taiwan's domestic COVID-19 vaccine producer Medigen Vaccine Biologics Corp. on Tuesday announced that it has officially applied to conduct Phase 3 clinical trials in Paraguay, Taiwan's only diplomatic ally in South America.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close down 3.81%
04/19/2024 02:02 PM - Society
Taiwan headline news
04/19/2024 10:56 AM - Politics
Health, labor, environment heads among new Cabinet members announced
04/19/2024 10:45 AM - Business
U.S. dollar up in Taipei trading
04/19/2024 10:24 AM - Business
Taiwan shares open lower
04/19/2024 09:09 AM